Emerging Molecularly Targeted Therapies in Castration Refractory Prostate Cancer

Androgen deprivation therapy (ADT) with medical or surgical castration is the mainstay of therapy in men with metastatic prostate cancer. However, despite initial responses, almost all men eventually develop castration refractory metastatic prostate cancer (CRPC) and die of their disease. Over the l...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Patel, Jesal C., Maughan, Benjamin L., Agarwal, Archana M., Batten, Julia A., Zhang, Tian Y., Agarwal, Neeraj
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2013
Matèries:
Review Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3684034/
https://ncbi.nlm.nih.gov/pubmed/23819055
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/981684
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars